Overview
This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.
Description
This is an observational study covering mainland China, and patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.
Eligibility
Inclusion Criteria:
- Computed tomography pulmonary angiography indicated that there were intraluminal defects
- Malignant histopathology was sarcoma
- Informed consent form was signed
Exclusion Criteria:
- Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma
- Expected inability to complete follow-up